I
t has been known for some time that BLCFCs are able to generate both endothelial and hematopoietic cells during mice ES cell differentiation, especially when stimulated by VEGF. But the exact mechanisms driving this development have remained unclear. An important finding in this context was the zebrafish mutant cloche (clo), which results in a defect of the endocard and substantial anemia. 1 Within this genetic cloche interval Wang et al were able to clone the Lycat gene. Lycat, a protein involved in the remodeling of cardiolipin, a mitochondrial structure and function protein, has never been discussed in stem-cell differentiation before. 2 Interestingly, even the mouse Lycat gene was able to partially rescue the cloche mutant phenotype (Jing-Wei Xiong, Qingming Yu, Jiaojiao Zhang, and John D. Mably, "An acyltransferase controls the generation of hematopoietic and endothelial lineages in zebrafish," manuscript submitted July 2007).
In the present study, the authors demonstrate a homology among zebrafish, mouse, and human Lycat genes that is highly conserved in its acyltransferase domain. The novelty of this study is based on the fact that the acyltransferase Lycat is involved in differentiation processes of EBs toward an endothelial and hematopoietic phenotype under in vitro conditions and that it is enriched in endothelial and hematopoietic progenitors of the bone marrow. We do not know which signaling pathway is utilized to achieve this goal. It remains for future studies to perform engrafting experiments with Lycat modified ES cells in mice to elucidate whether Lycat stays true to its attributed character under in vivo conditions. This would serve as a prerequisite to further exploration of this new pathway and eventual translation to clinical science.
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